Precision Biosciences (DTIL) Amortizatization of Intangibles (2020 - 2026)
Precision Biosciences (DTIL) reported Amortizatization of Intangibles of $341000.0 for Q1 2026, up 10.0% year-over-year from $310000.0 in Q1 2025, and up 2.4% quarter-over-quarter from $333000.0 in Q4 2025.
Precision Biosciences (DTIL) Amortizatization of Intangibles (2020 - 2026) Analysis & Trends
Precision Biosciences (DTIL) has 7 years of Amortizatization of Intangibles data on file, last reported at $341000.0 in Q1 2026.
- Amortizatization of Intangibles for Q1 2026 came in at $341000.0, up 10.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.3 million (up 9.76% YoY), and the FY2025 annual result was $1.3 million, up 9.55% from the prior year.
- Amortizatization of Intangibles climbed to $341000.0 in Q1 2026 per DTIL's latest filing, from $333000.0 in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $615000.0 in Q3 2024 and troughed at -$430000.0 in Q3 2023.
- A 5-year average of $203647.1 and a median of $297000.0 in 2022 frame the typical range for Amortizatization of Intangibles.
- The sharpest annual moves came in 2022 and 2025: Amortizatization of Intangibles sank 221.36% in 2022, then surged 1196.55% in 2025.
- A 5-year view of Amortizatization of Intangibles shows it stood at $85000.0 in 2022, then sank by 37.65% to $53000.0 in 2023, then surged by 471.7% to $303000.0 in 2024, then grew by 9.9% to $333000.0 in 2025, then advanced by 2.4% to $341000.0 in 2026.
- Business Quant data shows DTIL's Amortizatization of Intangibles at $341000.0 in Q1 2026, $333000.0 in Q4 2025, and $324000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Precision Biosciences | 168.99 Mn | 67.81 Mn | - | 341,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 341,000.00 |
| Mar 31, 2026 | 341,000.00 |
| Dec 31, 2025 | 333,000.00 |
| Dec 31, 2025 | 333,000.00 |
| Sep 30, 2025 | 324,000.00 |
| Sep 30, 2025 | 324,000.00 |
| Jun 30, 2025 | 318,000.00 |
| Jun 30, 2025 | 318,000.00 |
| Mar 31, 2025 | 310,000.00 |
| Mar 31, 2025 | 310,000.00 |
| Dec 31, 2024 | 303,000.00 |
| Dec 31, 2024 | 303,000.00 |
| Sep 30, 2024 | 615,000.00 |
| Sep 30, 2024 | 615,000.00 |
| Jun 30, 2024 | -29,000.00 |
| Jun 30, 2024 | -29,000.00 |
| Mar 31, 2024 | 284,000.00 |
| Mar 31, 2024 | 284,000.00 |
| Dec 31, 2023 | 53,000.00 |
| Dec 31, 2023 | 53,000.00 |